183 filings
Page 6 of 10
424B3
7h1jndngd9yb
28 Feb 22
Prospectus supplement
8:37am
8-K
wr6i vba2nrf
28 Feb 22
Gemini Therapeutics Provides Corporate Update
8:35am
424B3
c9b69
14 Jan 22
Prospectus supplement
8:02am
8-K
bnv3xkj5jehbhzx8ae
14 Jan 22
Departure of Directors or Certain Officers
8:00am
424B3
ac5h4ua9ge9
10 Jan 22
Prospectus supplement
8:10am
8-K
bo0m 82rfh
10 Jan 22
Gemini Therapeutics Provides GEM103 Program Update
8:05am
424B3
2um87g1vqmzfzvsurpn
15 Nov 21
Prospectus supplement
7:45am
8-K
i99dnlls7asyt7o3klrs
15 Nov 21
Gemini Therapeutics Reports Third Quarter 2021 Financial Results
7:35am
424B3
ym65rc238e72x
12 Nov 21
Prospectus supplement
8:38am
8-K
ouu kqtml
12 Nov 21
Gemini Therapeutics Announces Poster Presentation at AAO 2021
8:35am
S-8
uxlg vtm1r
14 Oct 21
Registration of securities for employees
4:02pm
424B3
f9acoc2nmnb lv8evn
6 Oct 21
Prospectus supplement
7:05am
8-K
5oba 7qyxoyb29r
6 Oct 21
Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic Atrophy
7:01am
424B3
razag7
1 Oct 21
Prospectus supplement
7:02am
8-K
f4ytjc15 ahxdrur
1 Oct 21
Submission of Matters to a Vote of Security Holders
7:00am
424B3
wgqyu57
9 Sep 21
Prospectus supplement
7:03am
8-K
o1gw grfxdbx9ij45ho
9 Sep 21
Departure of Directors or Certain Officers
7:00am
DEFA14A
4scnobltpmlrw2j
17 Aug 21
Additional proxy soliciting materials
7:14am
DEF 14A
qqzzoxj1et38o8ox
17 Aug 21
Definitive proxy
7:10am